Earningsreport

Q2/2023 6/30/2023 EPS 2.180 ZacksConsensus 0.420 ActVsEst 1.760 - Beat

NOVOZYMES A/S UNSP/ADR  (NVZMY) 
NASDAQ:AMEX Investor Relations: investors.novozymes.com